112 related articles for article (PubMed ID: 37797687)
1. The identification of cianidanol as a selective estrogen receptor beta agonist and evaluation of its neuroprotective effects on Parkinson's disease models.
Rymbai E; Sugumar D; Chakkittukandiyil A; Kothandan R; Selvaraj J; Selvaraj D
Life Sci; 2023 Nov; 333():122144. PubMed ID: 37797687
[TBL] [Abstract][Full Text] [Related]
2. Potential neuroprotective effect of androst-5-ene-3β, 17β-diol (ADIOL) on the striatum, and substantia nigra in Parkinson's disease rat model.
Salama RM; Tadros MG; Schaalan MF; Bahaa N; Abdel-Tawab AM; Khalifa AE
J Cell Physiol; 2018 Aug; 233(8):5981-6000. PubMed ID: 29266208
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of endoplasmic reticulum stress-activated IRE1α-TRAF2-caspase-12 apoptotic pathway is involved in the neuroprotective effects of telmisartan in the rotenone rat model of Parkinson's disease.
Tong Q; Wu L; Jiang T; Ou Z; Zhang Y; Zhu D
Eur J Pharmacol; 2016 Apr; 776():106-15. PubMed ID: 26879867
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effect of α-mangostin on mitochondrial dysfunction and α-synuclein aggregation in rotenone-induced model of Parkinson's disease in differentiated SH-SY5Y cells.
Hao XM; Li LD; Duan CL; Li YJ
J Asian Nat Prod Res; 2017 Aug; 19(8):833-845. PubMed ID: 28696167
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effects of Danshensu on rotenone-induced Parkinson's disease models in vitro and in vivo.
Wang T; Li C; Han B; Wang Z; Meng X; Zhang L; He J; Fu F
BMC Complement Med Ther; 2020 Jan; 20(1):20. PubMed ID: 32020857
[TBL] [Abstract][Full Text] [Related]
6. Artemisia Leaf Extract protects against neuron toxicity by TRPML1 activation and promoting autophagy/mitophagy clearance in both in vitro and in vivo models of MPP+/MPTP-induced Parkinson's disease.
Wu LK; Agarwal S; Kuo CH; Kung YL; Day CH; Lin PY; Lin SZ; Hsieh DJ; Huang CY; Chiang CY
Phytomedicine; 2022 Sep; 104():154250. PubMed ID: 35752074
[TBL] [Abstract][Full Text] [Related]
7. Fenofibrate promotes neuroprotection in a model of rotenone-induced Parkinson's disease.
Barbiero JK; Ramos DC; Boschen S; Bassani T; Da Cunha C; Vital MABF
Behav Pharmacol; 2022 Dec; 33(8):513-526. PubMed ID: 36094044
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective Effect of Phloretin in Rotenone-Induced Mice Model of Parkinson's Disease: Modulating mTOR-NRF2-p62 Mediated Autophagy-Oxidative Stress Crosstalk.
Shirgadwar SM; Kumar R; Preeti K; Khatri DK; Singh SB
J Alzheimers Dis; 2023; 94(s1):S109-S124. PubMed ID: 36463449
[TBL] [Abstract][Full Text] [Related]
9. Selective A
Fathalla AM; Soliman AM; Moustafa AA
Neurosci Lett; 2017 Mar; 643():89-96. PubMed ID: 28213070
[TBL] [Abstract][Full Text] [Related]
10. Chlorogenic Acid: a Polyphenol from Coffee Rendered Neuroprotection Against Rotenone-Induced Parkinson's Disease by GLP-1 Secretion.
Sharma N; Soni R; Sharma M; Chatterjee S; Parihar N; Mukarram M; Kale R; Sayyed AA; Behera SK; Khairnar A
Mol Neurobiol; 2022 Nov; 59(11):6834-6856. PubMed ID: 36048341
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-inducible factor 1 alpha and nuclear-related receptor 1 as targets for neuroprotection by albendazole in a rat rotenone model of Parkinson's disease.
Kandil EA; Sayed RH; Ahmed LA; Abd El Fattah MA; El-Sayeh BM
Clin Exp Pharmacol Physiol; 2019 Dec; 46(12):1141-1150. PubMed ID: 31408200
[TBL] [Abstract][Full Text] [Related]
12. Effect of centrophenoxine against rotenone-induced oxidative stress in an animal model of Parkinson's disease.
Verma R; Nehru B
Neurochem Int; 2009 Nov; 55(6):369-75. PubMed ID: 19375462
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effects of fingolimod in mouse models of Parkinson's disease.
Zhao P; Yang X; Yang L; Li M; Wood K; Liu Q; Zhu X
FASEB J; 2017 Jan; 31(1):172-179. PubMed ID: 27671228
[TBL] [Abstract][Full Text] [Related]
14. HCH6-1, an antagonist of formyl peptide receptor-1, exerts anti-neuroinflammatory and neuroprotective effects in cellular and animal models of Parkinson's disease.
Wang HL; Cheng YC; Yeh TH; Liu HF; Weng YH; Chen RS; Chen YC; Lu JC; Hwang TL; Wei KC; Liu YC; Wang YT; Hsu CC; Chiu TJ; Chiu CC
Biochem Pharmacol; 2023 Jun; 212():115524. PubMed ID: 37001680
[TBL] [Abstract][Full Text] [Related]
15. Naringin Exhibits Neuroprotection Against Rotenone-Induced Neurotoxicity in Experimental Rodents.
Garabadu D; Agrawal N
Neuromolecular Med; 2020 Jun; 22(2):314-330. PubMed ID: 31916219
[TBL] [Abstract][Full Text] [Related]
16. Protection against dopaminergic neurodegeneration in Parkinson's disease-model animals by a modulator of the oxidized form of DJ-1, a wild-type of familial Parkinson's disease-linked PARK7.
Inden M; Kitamura Y; Takahashi K; Takata K; Ito N; Niwa R; Funayama R; Nishimura K; Taniguchi T; Honda T; Taira T; Ariga H
J Pharmacol Sci; 2011; 117(3):189-203. PubMed ID: 22041943
[TBL] [Abstract][Full Text] [Related]
17. AC-186, a selective nonsteroidal estrogen receptor β agonist, shows gender specific neuroprotection in a Parkinson's disease rat model.
McFarland K; Price DL; Davis CN; Ma JN; Bonhaus DW; Burstein ES; Olsson R
ACS Chem Neurosci; 2013 Sep; 4(9):1249-55. PubMed ID: 23898966
[TBL] [Abstract][Full Text] [Related]
18. Molecular insights into the potential effects of selective estrogen receptor β agonists in Alzheimer's and Parkinson's diseases.
Rymbai E; Sugumar D; Chakkittukandiyil A; Kothandan R; Selvaraj D
Cell Biochem Funct; 2024 Apr; 42(3):e4014. PubMed ID: 38616346
[TBL] [Abstract][Full Text] [Related]
19. Lacosamide exhibits neuroprotective effects in a rat model of Parkinson's disease.
Bilal B; Kirazlar M; Erdogan MA; Yigitturk G; Erbas O
J Chem Neuroanat; 2023 Oct; 132():102311. PubMed ID: 37442244
[TBL] [Abstract][Full Text] [Related]
20. Tianma Gouteng Yin, a Traditional Chinese Medicine decoction, exerts neuroprotective effects in animal and cellular models of Parkinson's disease.
Liu LF; Song JX; Lu JH; Huang YY; Zeng Y; Chen LL; Durairajan SS; Han QB; Li M
Sci Rep; 2015 Nov; 5():16862. PubMed ID: 26578166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
